Available for the first time at Britain Against Cancer on 8 December are two new briefings from Cancer52: "Living with a rare or less...

Our thanks to Stopgap who have donated £400 to Cancer52. Stopgap is a small (50 people) owner managed business which finds marketing...

Chair Jonathan Pearce is interviewed on BBC Radio 4's Inside Health Programme on the Cancer Drug Fund and the extra challenges faced by...

Jonathan Pearce, Chair of Cancer52, said: "Cancer52 calls on NHS England to learn from The National Audit Office’s report[1] and ensure...

Cancer52 comment on Cancer Drug Fund announcement of 4 September 2015.

The Achieving World-Class Cancer Outcomes: A Strategy for England 2015-2020 was published in July 2015. Cancer52, a coalition of more...

We are delighted to announce that our new report “Rare and Less Common Cancers: Incidence and Mortality in England, 2010 to 2013” is...

Following our successful Parliamentary event in December, details of how the last government answered our questions on rare and less...

On 23 April, Cancer52 responded to the NHS public consultation on Investing in Specialised Services. Read more of our submission.

Cancer52 is delighted to announce that Jonathan Pearce, chief executive of the Lymphoma Association, has been appointed as Chair of...